I was excited to interview Rahul for our podcast since his background before starting Clora is very deep in the life sciences industry as the head of clinical development at several biopharma companies. It was an opportunity to explore this industry, as I haven’t interviewed anyone who has the same depth of experience, so we talk about the drug discovery and clinical trials process.
It was this industry knowledge that led Rahul down the path of starting Clora to address a critical pain point in the life sciences industry and that is the lack of resources. And, when I say resources… I’m referring to talent and having the right expertise at the right time during the drug discovery process. As you’ll hear, it takes over 300 unique skillsets to bring a drug to market.
Well, Clora is helping to solve this talent crisis with its intelligent platform that efficiently matches life science companies with flexible, on-demand expertise. The company is venture backed by Spark Capital, Social Capital, Notation Capital, and others.
Rahul is also a fellow podcaster, as he is one of the hosts of the Biotech 2050 Podcast, which I would recommend checking out if you are interested in learning more about the biotech and life sciences industry.
In this episode of our podcast, we cover:
- What’s the biggest difference between building a tech startup versus a life sciences company.
- Rahul’s background story and why he pursued a career in the life sciences industry.
- His experience leading clinical development across multiple companies.
- All the details about Clora in terms of their mission, the details on their platform, and growth plans ahead.
- Advice for founders on building a company in the healthtech industry.
- And so much more.